Oaktree Acquisition Corp. III Life Sciences financial data

Symbol
OACC, OACCU, OACCW on Nasdaq
Location
Los Angeles, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 147 %
Debt-to-equity -124 %

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) -226K USD -369%
Nonoperating Income (Expense) 2.19M USD
Net Income (Loss) Attributable to Parent 1.97M USD

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.33M USD
Assets, Current 1.48M USD
Assets 201M USD
Liabilities, Current 1.23M USD
Liabilities 8.25M USD
Retained Earnings (Accumulated Deficit) -6.77M USD
Stockholders' Equity Attributable to Parent -6.76M USD -29191%
Liabilities and Equity 201M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -75.6K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.33M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares
Additional Paid in Capital 0 USD
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares